Targeting farnesyl pyrophosphate synthase of Trypanosoma cruzi by fragment-based lead discovery
Trypanosoma cruzi (T. cruzi) is the causative agent of Chagas disease (CD), which mostly affects underprivileged populations in South and Central America. The current standard of care for this disease are the two empirically discovered drugs benznidazole and nifurtimox. They show low efficacy, diffi...
Gespeichert in:
主要作者: | |
---|---|
其他作者: | |
格式: | Dissertation |
語言: | 英语 |
出版: |
Philipps-Universität Marburg
2019
|
主題: | |
在線閱讀: | PDF-Volltext |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
成為第一個發表評論!